(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

ORBACTIV (ORITAVANCIN)

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

ORBACTIV (ORITAVANCIN)

ST13

US500000087935592

Class

5

Filing

87935592

Registration

6583832

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

68

Latest update

09/25/2025

Trademark type

Combined

Nice classes

5

Filing date

05/24/2018

Registration date

12/07/2021

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

12/07/2021

Last transaction

09/25/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

06/29/2018

First use in commerce

06/29/2018

Drawing code

3

Owner type

16

Owner location

Parsippany, NJ

Examiner

RYDLAND,STEPHANIE DIANA

Law office

N40

Current location

TMO LAW OFFICE 122

Mark description

The mark consists of the word "ORBACTIV" in bold large lettering and underneath is the word "(ORITAVANCIN)" in less bold, slightly smaller lettering. To the left is a series of curved lines forming an open spiral design with a dot on the top right of the outermost curved line.

Holders and representatives

Holders

Melinta Therapeutics, LLC
Melinta Therapeutics, Inc.
Melinta Therapeutics, Inc.

Representatives

Jorge Arciniega Loeb & Loeb LLP

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

pharmaceutical preparationsanti-infective preparations and substances containing oritavancin

Publications

History of USPTO decisions and trademark events.

68 publications found

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

09/24/2025

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

06/12/2025

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

06/12/2025

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

06/12/2025

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

06/12/2025

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

06/12/2025

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

10/26/2022

COC.

CORRECTION UNDER SECTION 7 - PROCESSED

05/11/2022

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

05/11/2022

ES7R

TEAS SECTION 7 REQUEST RECEIVED

12/22/2021

R.PR

REGISTERED-PRINCIPAL REGISTER

12/07/2021

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

11/03/2021

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

11/02/2021

DOCK

ASSIGNED TO EXAMINER

11/02/2021

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

10/19/2021

SUPC

STATEMENT OF USE PROCESSING COMPLETE

10/18/2021

EX5G

SOU EXTENSION 5 GRANTED

10/18/2021

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

10/08/2021

IUAF

USE AMENDMENT FILED

08/25/2021

EISU

TEAS STATEMENT OF USE RECEIVED

08/25/2021

EXT5

SOU EXTENSION 5 FILED

08/23/2021

EEXT

SOU TEAS EXTENSION RECEIVED

08/23/2021

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

08/18/2021

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

03/02/2021

EX4G

SOU EXTENSION 4 GRANTED

02/26/2021

EXT4

SOU EXTENSION 4 FILED

02/26/2021

EEXT

SOU TEAS EXTENSION RECEIVED

02/26/2021

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

01/13/2021

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

08/28/2020

EX3G

SOU EXTENSION 3 GRANTED

08/26/2020

EXT3

SOU EXTENSION 3 FILED

08/26/2020

EEXT

SOU TEAS EXTENSION RECEIVED

08/26/2020

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

07/29/2020

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

07/29/2020

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

07/29/2020

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

07/29/2020

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

07/29/2020

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

07/29/2020

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

03/07/2020

EX2G

SOU EXTENSION 2 GRANTED

03/06/2020

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

03/06/2020

EXT2

SOU EXTENSION 2 FILED

02/25/2020

EEXT

SOU TEAS EXTENSION RECEIVED

02/25/2020

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

08/28/2019

EX1G

SOU EXTENSION 1 GRANTED

08/26/2019

EXT1

SOU EXTENSION 1 FILED

08/26/2019

EEXT

SOU TEAS EXTENSION RECEIVED

08/26/2019

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

02/26/2019

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

01/01/2019

PUBO

PUBLISHED FOR OPPOSITION

01/01/2019

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

12/12/2018

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

11/21/2018

XAEC

EXAMINER'S AMENDMENT ENTERED

11/21/2018

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

11/21/2018

GNEA

EXAMINERS AMENDMENT E-MAILED

11/21/2018

CNEA

EXAMINERS AMENDMENT -WRITTEN

11/21/2018

ZZZX

PREVIOUS ALLOWANCE COUNT WITHDRAWN

11/13/2018

PBCR

WITHDRAWN FROM PUB - OG REVIEW QUERY

11/06/2018

ALIE

ASSIGNED TO LIE

10/19/2018

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

10/01/2018

XAEC

EXAMINER'S AMENDMENT ENTERED

09/18/2018

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

09/18/2018

GNEA

EXAMINERS AMENDMENT E-MAILED

09/18/2018

CNEA

EXAMINERS AMENDMENT -WRITTEN

09/18/2018

DOCK

ASSIGNED TO EXAMINER

09/14/2018

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

06/05/2018

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

06/02/2018

NWAP

NEW APPLICATION ENTERED

05/28/2018

Continuous trademark protection

Get notified about every new filing that threatens ORBACTIV (ORITAVANCIN) or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.